Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals
10.3760/cma.j.issn.0253-3758.2011.05.004
- VernacularTitle:中国39家大医院动脉粥样硬化性心脑血管病患者他汀类药物应用现状调查
- Author:
Dan ZAHNG
1
;
Lei GE
;
Jing LI
;
Xi LI
;
Fang FENG
;
Yi-Ping CHEN
;
Zheng-Ming CHEN
;
Martin LANDRAY
;
Jane ARMITAGE
;
Fang CHEN
;
Li-Xin JIANG
;
On behalf of HPS2-THRIVE collaborative group
Author Information
1. 中国医学科学院,北京协和医学院,心血管病研究所,阜外心血管病医院
- Keywords:
Atherosclerotic disease;
Cerebrovascular accident;
Lipid regulating drugs;
Secondary prevention
- From:
Chinese Journal of Cardiology
2011;39(5):397-401
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the current statin use among high-risk patients with atherosclerotic cardiovascular diseases in Chinese large hospitals.Methods Clinical history and current medication were recorded in 11 783 patients with a history of atherosclerotic cardiovascular disease(CVD)from 39 highest-ranking hospitals in 10 Chinese cities.Results Indication for statin use was given for all screened patients and statin was not prescribed in up to 59.6% (7022)patients. For patients with statin use, medication time was shorter than their atherosclerotic CVD history in 1120 (23.5%) patients. The proportion of statin use among patients with ischemic stroke was 19.6%,among patients with coronary heart disease without ischemic stroke was 59.2%.Conclusion Statin is underused in secondary prevention among patients with atherosclerotic CVD in China.There is a large gap between guideline recommended statin use and in practice.Thus,it remains a major challenge for healthcare professionals and policy makers to resolve this problem rapidly.
